Myriad’s Prolaris Test Significantly Improves the Risk…

Myriad Genetics, Inc. , a global leader in personalized medicine, today announced new data demonstrating the utility of the ProlarisA test to more accurately classify mortality risk and guide the management of newly diagnosed men with prostate cancer. The data are being presented at the 2017 Genitourinary Cancers Symposium meeting in Orlando, Fla.

Genetic Testing Your Health

If one or more close family members has a disease with a genetic link, testing for the gene may make sense. In some diseases, genetic testing gives doctors the ability to detect problems early.

Will Seattle Genetics’ Deal With Immunomedics Get Scuttled?

The deal could be a big win for Seattle Genetics, but it doesn’t have the full support of all of Immunomedics investors. After the closing market bell on Friday, venBio Select Advisors, LLC — the beneficial owner of 9.9% of Immunomedics shares — said Immunomedics’ board of directors is “giving away its crown jewel.”

Health Notes: Go with the Flow to dodge air pollution

The world’s first air pollution tracker has been launched in an effort to help cyclists and other commuters steer clear of toxic ‘hotspots’ while travelling in cities. Air pollution reached a six-year high in London last month, forcing health chiefs to issue a warning to city-dwellers to stay indoors to protect their health – part of a global problem.

Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify …

Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a privately held biotech company based in Madison, Wisconsin and Cambridge, Massachusetts, today announced that they have entered into a collaboration to identify novel biomarkers of Angelman syndrome by analyzing metabolomic profile data as part of Ovid’s ongoing randomized, double-blind, placebo-controlled Phase 2 clinical trial .

Your heart will thank you if you do these things

If you’ve taken the steps to cease and desist some of your more unhealthy habits, it’s now time to add some healthy ones to your arsenal. Putting a priority on heart health will allow you to have a fulfilling and active lifestyle and will contribute to fewer visits to the doctor.

Studies reveal link between rotator cuff disease and genetics

A new study presented this week at the Association of Academic Physiatrists Annual Meeting in Las Vegas shows rotator cuff disease might be a heritable trait. Rotator cuff disease is a common disorder that affects 30 to 50 percent of people over the age of 50. The disease often leads to shoulder pain and loss of function.

Genes point to who develops lung disease, study finds

Scientists unveiled a trove of newly-discovered gene variants on Monday to help predict who will most likely develop a killer lung disease, both among smokers and non-smokers. The world’s biggest probe of the genetics of lung health yielded 43 new gene variants linked to chronic obstructive pulmonary disease , a major cause of death.

Square advice on your new hip

When a friend of mine went to China a couple of years ago, he experienced difficulty navigating the Great Wall because of osteoarthritis of his hip. When he got back home and had to crawl up the steps to his bedroom, he realized it was time to have his hip replaced.

Gene variants can add 2cm to your height

PIC: Chandra Bahadur Dangi, from Nepal, the shortest adult in the world, poses for pictures with the world’s tallest man Sultan Kosen from Turkey, during a photocall in London on November 13, 2014. Researchers have unveiled 83 rare gene variants which exert a strong influence on human height, with some capable of adding or subtracting more than two centimetres .

Scientists shocked by discovery about brains

… USC Viterbi School of Engineering. The researchers analyzed data of 3,647 65- to 79-year-old women from the Women’s Health Initiative Memory Study (WHIMS). These women lived across 48 states and did not have dementia when they enrolled. The …

European researchers highlight potential of xenografts in cancer research and treatment

European research lays the foundation for the development of new and ambitious research projects with xenografts derived from patients, preclinical models with great potential to advance research and treatment in cancer. The review article, published in Nature Reviews Cancer , is the result of the joint work of the European consortium of researchers EurOPDX, which includes different researchers from the Bellvitge Biomedical Research Institute – Catalan Institute of Oncology , among which there are Eva Gonzalez-Suarez and Alberto Villanueva.

Defects in key gene spur breast and ovarian cancer growth, study shows

Defects in a key gene – long thought to drive cancer by turning off the protection afforded by the well-known BRCA genes – spur cancer growth on their own, according to a study led by researchers from NYU Langone Medical Center. The study gene, known as EMSY, has some of the same functions as BRCA1 and BRCA2, which are known to protect against breast and ovarian cancer when normal.

Aevi Genomic Medicine Announces Enrollment of First Patient in Phase…

“We are pleased to have the first patient enrolled into this important study,” said Garry Neil, Chief Scientific Officer of Aevi Genomic Medicine. “Patients with 22q Deletion Syndrome often suffer from a range of debilitating psychiatric conditions, including anxiety disorders, ASD, and ADHD, with many patients progressing to psychosis and schizophrenia.

Dimension Announces Interim Topline Results from Ongoing Phase 1/2…

Dimension Announces Interim Topline Results from Ongoing Phase 1/2 Clinical Program for DTX101, Dimension’s Lead AAV Product Candidate in Development for Adult Patients with Moderate/Severe to Severe Hemophilia B CAMBRIDGE, Mass., Jan. 31, 2017 — Dimension Therapeutics, Inc. , a biopharmaceutical company advancing novel, adeno-associated virus gene therapies targeting the liver, a key organ for human metabolism, today announced preliminary topline safety and early efficacy results of Dimension’s multi-center phase 1/2 study of DTX101 for the treatment of adult patients with moderate/severe to severe hemophilia B. DTX101, Dimension’s lead AAV candidate, is designed to deliver stable expression of blood clotting Factor IX in patients with hemophilia B, a rare genetic bleeding disorder resulting from a deficiency in FIX.

Jefferson researchers reveal new insight into two states of viral protein

To generate swarms of new viral particles, a virus hijacks a cell into producing masses of self-assembling cages that are then loaded with the genetic blueprint for the next infection. But the picture of how that DNA is loaded into those viral cages, or capsids, was blurry, especially for two of the most common types of DNA virus on earth, bacterial viruses and human herpesvirus.

Busy minds may be better at fighting dementia

Mentally stimulating activities can protect your brain against aging, even if you’re genetically predisposed toward dementia or Alzheimer’s disease , a new study reports. Activities that keep the brain busy — using a computer, crafting, playing games and participating in social activities — appear to lower the risk of age-related mental decline in people 70 and older, the Mayo Clinic study found.